Concepedia

Kaela Parkhouse

KP

Statistics

Publications

14

Citations

2.6K

H-Index

13

Active since

2014

Affiliations

University of Pennsylvania(Current)

University of Chicago

Acuitas Therapeutics (Canada)

Children's Hospital of Philadelphia

The Wistar Institute

Kaela Parkhouse is an author at University of Pennsylvania specializing in influenza vaccines, medicine, and vaccination.

ORCID

Top concepts

Publications per year

2014–2022

14

Publications

14

Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains

Seth J. Zost, Kaela Parkhouse, Megan E. Gumina et al. · Proceedings of the National Academy of Sciences · 2017 · 561 citations · Full text

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses

Norbert Pardi, Michael J. Hogan, Martin S. Naradikian et al. · The Journal of Experimental Medicine · 2018 · 501 citations · Full text

A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes

Claudia P. Arevalo, Marcus J. Bolton, Valerie Le Sage et al. · Science · 2022 · 325 citations · Full text

, , +13

Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies

Norbert Pardi, Kaela Parkhouse, Ericka Kirkpatrick et al. · Nature Communications · 2018 · 276 citations · Full text

Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013–2014 influenza season

Susanne L. Linderman, Benjamin S. Chambers, Seth J. Zost et al. · Proceedings of the National Academy of Sciences · 2014 · 233 citations · Full text

Rows per page

1–5 of 14